August 13, 2010 08:30 PM Eastern Daylight Time 

Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Unica Corporation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Unica Corporation (“Unica” or the “Company”) (NASDAQ:UNCA) related to the Company’s agreement to be acquired by IBM. The proposed cash transaction is valued at approximately $480 million.

Under the terms of the definitive agreement entered into by the parties, IBM will acquire all of the outstanding shares of Unica stock for $21.00 per share in cash. The transaction is expected to close in the fourth quarter of 2010. Upon completion of the transaction, Unica’s employees will become part of IBM's Software Solutions Group. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the proposed transaction by Unica’s board of directors.

If you own shares of Unica, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

August 13, 2010 08:10 PM Eastern Daylight Time 

SAN DIEGO--(BUSINESS WIRE)--Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Dynegy Inc. ("Dynegy" or the "Company") (NYSE: DYN) in connection with their efforts to sell Dynegy to an affiliate of The Blackstone Group L.P. ("Blackstone") (NYSE: BX). If the transaction is completed, Dynegy shareholders will receive $4.50 in cash for each share of Dynegy stock they hold. The transaction is expected to close by the end of 2010.

Robbins Umeda LLP's investigation concerns whether the Board of Directors of Dynegy undertook a fair process to obtain fair consideration for all shareholders of Dynegy. Notably, a little over one month ago, Dynegy's stock traded above the buyout price and even traded as high as $5.35 on May 28, 2010. Earlier this year, the Company's stock traded at over $9.00 per share, more that twice what Blackstone's affiliate is offering. Additionally, at least one analyst has set a price target for Dynegy of $7.50 per share, $3.00 higher than the value of Blackstone's affiliate's offer.

If you are a shareholder of Dynegy, plan to continue to hold your shares, and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at info@robbinsumeda.com.

August 09, 2010 08:08 PM Eastern Daylight Time 

SAN DIEGO--(BUSINESS WIRE)--Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Superior Well Services, Inc. ("Superior Well" or the "Company") (NYSE: SWSI) in connection with their efforts to sell Superior Well to Nabors Industries Ltd. ("Nabors"). If the transaction is completed, Superior Well shareholders will receive $22.12 in cash for each share of Superior Well stock they hold. Nabors expects the offer to close by the end of the third quarter.

Robbins Umeda LLP's investigation concerns whether the Board of Directors of Superior Well undertook a fair process to obtain fair consideration for all shareholders of Superior Well. Specifically, our investigation concerns whether the Company's Board of Directors breached their fiduciary duties to Superior Well shareholders by failing to adequately shop the Company before entering into the transaction with Nabors. Notably, the Company has recently improved liquidity with amendments to credit facility, temporarily increasing total capacity under credit facility to $90 million, up from $75 million. Additionally, at least one analyst has set a price target for Superior Well of $25.00 per share, $2.88 higher than the implied value of Nabors' offer.

If you are a shareholder of Superior Well, plan to continue to hold your shares, and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at info@robbinsumeda.com.

August 09, 2010 08:12 PM Eastern Daylight Time 

The Briscoe Law Firm, PLLC, and Powers Taylor, LLP, Announce the Investigation of Possible Breaches of Fiduciary Duties Concerning the Acquisition of Penwest Pharmaceuticals Co.

DALLAS--(BUSINESS WIRE)--The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Powers Taylor, LLP, are investigating potential legal claims against the Board of Directors of Penwest Pharmaceuticals Co. (“PPCO” or “Company”) (NASDAQ:PPCO) related to the proposed acquisition of SWSI by Nabors Industries Ltd.

The agreement, which was announced on Monday, August 9, 2010, involves a cash transaction valued at approximately $144 million, under which the Company shareholders will receive $5.00 in cash for each share of PPCO common stock they hold. The investigation relates to possible breaches of fiduciary duty and other violations of state law by the Board of Directors of PPCO for approving this transaction, whether the consideration to be received by PPCO shareholders is fair, and whether PPCO’s Board of Directors acted in the shareholders’ best interests.

If you currently own shares of PPCO and would like additional information regarding this investigation, or if you have information regarding the allegations involving this transaction, please contact Patrick Powers at Powers Taylor, LLP, toll free, 877-728-9607, via e-mail at patrick@cptlawfirm.com, or The Briscoe Law Firm, PLLC, toll free, 877-397-5991, or via email at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you.

合理價格約 6.35 6.43 6.51塊

Aug. 5, 2010, 8:30 p.m. EDT · Recommend · Post:

Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of ExpressJet Holdings, Inc.

June 16, 2010 09:30 PM Eastern Daylight Time 

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Somanetics Corporation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Somanetics Corporation (“Somanetics” or the “Company”) (NASDAQ:SMTS) related to the Company’s agreement to be acquired by Covidien plc (“Covidien”). The proposed transaction is valued at approximately $250 million.

Under the terms of the definitive merger agreement entered into by the parties, a wholly owned subsidiary of Covidien will commence a tender offer to acquire all of the outstanding shares of Somanetics for $25.00 per share in cash, followed by a second-step merger. The proposed transaction is expected to be completed by July 31, 2010. In connection with the tender offer, all of the directors and executive officers of Somanetics have agreed to tender their shares into the offer. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Somanetics’ board of directors.

If you own shares of Somanetics, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

June 02, 2010 04:10 PM Eastern Daylight Time 

NEW YORK--(BUSINESS WIRE)--Fitch Ratings has affirmed Covidien plc's (Covidien) ratings as follows:

--Issuer Default Rating (IDR) at 'A';

--Short-term IDR at 'F1';

Bard to Acquire SenoRx

合理價格約19.75-18.82